Publication | Closed Access

Sequential vinorelbine–capecitabine followed by docetaxel in advanced breast cancer: long-term results of a pilot phase II trial

Advanced Breast CancerBreast OncologyMedicinePharmacologySequential Vinorelbine–capecitabineBreast CancerPharmacotherapyAnti-cancer AgentCancer TreatmentOncologyRadiation OncologyMolecular OncologyLong-term Results